Author
Listed:
- Gathoni Kamuyu
(UK Health Security Agency)
- Filomeno Coelho da Silva
(UK Health Security Agency)
- Vanessa Tenet
(Prevention and Infections Branch)
- John Schussler
(Information Management Services Inc)
- Anna Godi
(UK Health Security Agency)
- Rolando Herrero
(Fundación INCIENSA (FUNIN))
- Carolina Porras
(Fundación INCIENSA (FUNIN))
- Lisa Mirabello
(National Cancer Institute)
- John T. Schiller
(National Cancer Institute)
- Mónica S. Sierra
(National Cancer Institute)
- Aimée R. Kreimer
(National Cancer Institute)
- Gary M. Clifford
(Prevention and Infections Branch)
- Simon Beddows
(UK Health Security Agency
UK Health Security Agency)
Abstract
Human Papillomavirus (HPV) type variants have been classified into lineages and sublineages based upon their whole genome sequence. Here we have examined the specificity of antibodies generated following natural infection with lineage variants of oncogenic types (HPV16, 18, 31, 33, 45, 52 and 58) by testing serum samples assembled from existing archives from women residing in Africa, The Americas, Asia or Europe against representative lineage-specific pseudoviruses for each genotype. We have subjected the resulting neutralizing antibody data to antigenic clustering methods and created relational antigenic profiles for each genotype to inform the delineation of lineage-specific serotypes. For most genotypes, there was evidence of differential recognition of lineage-specific antigens and in some cases of a sufficient magnitude to suggest that some lineages should be considered antigenically distinct within their respective genotypes. These data provide compelling evidence for a degree of lineage specificity within the humoral immune response following natural infection with oncogenic HPV.
Suggested Citation
Gathoni Kamuyu & Filomeno Coelho da Silva & Vanessa Tenet & John Schussler & Anna Godi & Rolando Herrero & Carolina Porras & Lisa Mirabello & John T. Schiller & Mónica S. Sierra & Aimée R. Kreimer & G, 2024.
"Global evaluation of lineage-specific human papillomavirus capsid antigenicity using antibodies elicited by natural infection,"
Nature Communications, Nature, vol. 15(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-45807-w
DOI: 10.1038/s41467-024-45807-w
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-45807-w. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.